Drugs / Streptococcus Dentisani CECT 7746
Streptococcus Dentisani CECT 7746
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03468842 Comparator | May 2016 → Mar 2017 | dental caries | AB Biotics, SA | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Streptococcus Dentisani CECT 7746 | “Study to Evaluate the Clinical Efficacy of Streptococcus Dentisani CECT 7746 in Caries Risk Reduction” NCT03468842 ↗ |
| Action | Inhibit | “These strains have demonstrated, through in vitro studies, an enormous potential of inhibition against S. mutans” NCT03468842 ↗ |
| Modality | Other / unclassified | “The probiotic Streptococcus dentisani is a bacterial species present in the human oral microbial flora.” NCT03468842 ↗ |
| Route | Oral | “Application in mouth of a bucoadhesive gel.” NCT03468842 ↗ |